McGuire Investment Group LLC Has $16.87 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

McGuire Investment Group LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 187,308 shares of the exchange traded fund’s stock after selling 3,164 shares during the period. SPDR S&P Biotech ETF comprises about 2.4% of McGuire Investment Group LLC’s holdings, making the stock its 15th biggest position. McGuire Investment Group LLC’s holdings in SPDR S&P Biotech ETF were worth $16,869,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in XBI. FMR LLC grew its holdings in shares of SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after purchasing an additional 830 shares in the last quarter. Ameritas Advisory Services LLC boosted its position in shares of SPDR S&P Biotech ETF by 11.9% during the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after acquiring an additional 1,137 shares in the last quarter. Beaton Management Co. Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $212,000. Robinson Value Management Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 1.2% during the 3rd quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock valued at $1,329,000 after acquiring an additional 155 shares in the last quarter. Finally, Granite Bay Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 4,965.8% during the 2nd quarter. Granite Bay Wealth Management LLC now owns 124,062 shares of the exchange traded fund’s stock valued at $11,097,000 after acquiring an additional 121,613 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $92.46 on Friday. The firm’s 50-day simple moving average is $93.34 and its 200-day simple moving average is $96.88. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The firm has a market cap of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.